Het percentage terugval na afloop van de nabehandelingsfase was iets hoger in de fluoxetinegroep (28%) dan in de clomipraminegroep (23%). ###>The rate of relapse at the end of the post-treatment phase was slightly higher in the fluoxetine group (28%) than in the clomipramine group (23%).